GLOBUS MEDICAL, INC. Excess Tax Benefit from Share-based Compensation, Financing Activities
GLOBUS MEDICAL, INC. (GMED) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $1.57 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2017-11-09
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-12-31 was $3.07M, a 3888.31% increase year-over-year.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-09-30 was -$700.00K, a 206.71% decline year-over-year.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-06-30 was -$300.00K, a 147.39% decline year-over-year.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-03-31 was -$500.00K, a 173.10% decline year-over-year.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2016 was $1.57M, a 23.37% decline from fiscal 2015.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $2.05M, a 53.49% decline from fiscal 2014.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2014 was $4.41M, a 7.32% decline from fiscal 2013.
- GLOBUS MEDICAL, INC. excess tax benefit from share-based compensation, financing activities for fiscal 2013 was $4.76M, a 78.73% increase from fiscal 2012.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month as first filed | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month as first filed | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month as first filed | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2016-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $2.37M derived: sum of 2 quarters · filed 2017-11-09 | $2.07M derived: sum of 3 quarters · filed 2017-11-09 | $1.57M 10-K · filed 2017-03-16 | |||
| 2016-09-30 | -$700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$1.00M derived: sum of 2 quarters · filed 2017-11-09 | -$1.50M 10-Q · filed 2017-11-09 | $1.48M 10-Q · filed 2016-11-09 | -$1.42M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$800.00K 10-Q · filed 2017-08-03 | $764.00K 10-Q · filed 2016-07-27 | -$723.00K derived: sum of 3 quarters · filed 2017-08-03 | -$67.00K derived: sum of 4 quarters · filed 2017-08-03 | ||
| 2016-03-31 | -$500.00K 10-Q · filed 2017-05-04 | $510.00K 10-Q · filed 2016-05-04 | -$423.00K derived: sum of 2 quarters · filed 2017-05-04 | $233.00K derived: sum of 3 quarters · filed 2017-05-04 | $866.00K derived: sum of 4 quarters · filed 2017-05-04 | ||
| 2015-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $733.00K derived: sum of 2 quarters · filed 2017-03-16 | $1.37M derived: sum of 3 quarters · filed 2017-03-16 | $2.05M 10-K · filed 2017-03-16 | |||
| 2015-09-30 | $656.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.29M derived: sum of 2 quarters · filed 2016-11-09 | $1.97M 10-Q · filed 2016-11-09 | $2.34M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $633.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $1.32M 10-Q · filed 2016-07-27 | $1.68M derived: sum of 3 quarters · filed 2017-03-16 | $1.88M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $684.00K 10-Q · filed 2016-05-04 | $1.05M derived: sum of 2 quarters · filed 2017-03-16 | $1.25M derived: sum of 3 quarters · filed 2017-03-16 | $2.31M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $567.00K derived: sum of 2 quarters · filed 2017-03-16 | $1.62M derived: sum of 3 quarters · filed 2017-03-16 | $4.41M 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $1.26M derived: sum of 2 quarters · filed 2015-11-04 | $4.04M 10-Q · filed 2015-11-04 | $4.28M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $3.84M 10-Q · filed 2015-07-31 | $4.08M derived: sum of 3 quarters · filed 2016-02-29 | $6.41M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $2.79M 10-Q · filed 2015-05-05 | $3.02M derived: sum of 2 quarters · filed 2016-02-29 | $5.36M derived: sum of 3 quarters · filed 2016-02-29 | $7.24M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.57M derived: sum of 2 quarters · filed 2016-02-29 | $4.45M derived: sum of 3 quarters · filed 2016-02-29 | $4.76M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $4.22M derived: sum of 2 quarters · filed 2014-10-31 | $4.52M 10-Q · filed 2014-10-31 | $4.54M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2013-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $2.19M 10-Q · filed 2014-08-06 | $2.20M derived: sum of 3 quarters · filed 2015-02-26 | $4.79M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2013-03-31 | $303.00K 10-Q · filed 2014-04-30 | $320.00K derived: sum of 2 quarters · filed 2015-02-26 | $2.91M derived: sum of 3 quarters · filed 2015-02-26 | $2.94M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2012-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $2.60M derived: sum of 2 quarters · filed 2015-02-26 | $2.64M derived: sum of 3 quarters · filed 2015-02-26 | $2.66M 10-K · filed 2015-02-26 | |||
| 2012-09-30 | $2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $2.62M derived: sum of 2 quarters · filed 2013-10-31 | $2.64M 10-Q · filed 2013-10-31 | -$2.64M 10-Q · filed 2012-11-02 | $2.64M derived: sum of 4 quarters · filed 2014-03-14 | ||
| 2012-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $57.00K 10-Q · filed 2013-08-02 | $57.00K derived: sum of 3 quarters · filed 2014-03-14 | $87.00K derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-03-31 | $24.00K 10-Q · filed 2013-05-03 | $24.00K derived: sum of 2 quarters · filed 2014-03-14 | $54.00K derived: sum of 3 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $30.00K derived: sum of 2 quarters · filed 2014-03-14 | $54.00K 10-K · filed 2014-03-14 | ||||
| 2011-09-30 | $30.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-02 | $54.00K 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | $24.00K 10-Q/A · filed 2012-09-19 | ||||||
| 2010-12-31 | $787.00K 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |